Zoryl 4 Tablet

The medication is effective in improving glycemic control and may be used as monotherapy or in combination with other antidiabetic agents such as metformin or insulin. Glimepiride has a rapid onset of action and a prolonged duration, allowing once-daily dosing for improved patient compliance. It is essential to monitor blood glucose levels regularly during therapy to avoid hypoglycemia, a common adverse effect associated with sulfonylureas.

Other potential side effects include weight gain, gastrointestinal disturbances, and allergic reactions. Zoryl 4 should be used cautiously in patients with hepatic or renal impairment, and contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or known hypersensitivity to sulfonylureas. Patient education on diet, exercise, and recognition of hypoglycemia symptoms is crucial for optimal therapeutic outcomes.

Always consult a healthcare professional before initiating or adjusting therapy with Zoryl 4 Tablet.